
Results
2
2 companies
Newron Pharmaceuticals
Market Cap: CHF 389.9m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 19.48
7D
3.3%
1Y
89.1%
Cosmo Pharmaceuticals
Market Cap: CHF 1.8b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 115.20
7D
0.5%
1Y
79.2%